Ladenburg Thalmann Financial Services’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $2K | Buy |
1,110
+1,090
| +5,450% | +$1.96K | ﹤0.01% | 5152 |
|
2019
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 5671 |
|
2019
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 5607 |
|
2019
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 5556 |
|
2018
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 5561 |
|
2018
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 5580 |
|
2018
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 5238 |
|
2018
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 5367 |
|
2017
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 5288 |
|
2017
Q3 | $0 | Sell |
20
-100
| -83% | – | ﹤0.01% | 5205 |
|
2017
Q2 | $0 | Hold |
120
| – | – | ﹤0.01% | 5146 |
|
2017
Q1 | $1K | Hold |
120
| – | – | ﹤0.01% | 4820 |
|
2016
Q4 | $0 | Hold |
120
| – | – | ﹤0.01% | 5129 |
|
2016
Q3 | $0 | Hold |
120
| – | – | ﹤0.01% | 5074 |
|
2016
Q2 | $0 | Hold |
120
| – | – | ﹤0.01% | 5052 |
|
2016
Q1 | $1K | Hold |
120
| – | – | ﹤0.01% | 4653 |
|
2015
Q4 | $1K | Sell |
120
-7
| -6% | -$58 | ﹤0.01% | 4644 |
|
2015
Q3 | $2K | Hold |
127
| – | – | ﹤0.01% | 4357 |
|
2015
Q2 | $2K | Sell |
127
-12
| -9% | -$189 | ﹤0.01% | 4436 |
|
2015
Q1 | $2K | Buy |
139
+12
| +9% | +$173 | ﹤0.01% | 4369 |
|
2014
Q4 | $3K | Hold |
127
| – | – | ﹤0.01% | 4004 |
|
2014
Q3 | $3K | Hold |
127
| – | – | ﹤0.01% | 3638 |
|
2014
Q2 | $4K | Hold |
127
| – | – | ﹤0.01% | 3505 |
|
2014
Q1 | $4K | Buy |
127
+92
| +263% | +$2.9K | ﹤0.01% | 3392 |
|
2013
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 3702 |
|
2013
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 3669 |
|
2013
Q2 | $0 | Buy |
+35
| New | – | ﹤0.01% | 3783 |
|